Abstract: Pharmaceutical compositions and methods are described comprising at least a parathyroid hormone peptide (PTH) preferably PTH1-34 and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of PTH, for treating or preventing osteoporosis or osteopenia in a mammalian subject, preferably a human.
Type:
Grant
Filed:
October 17, 2006
Date of Patent:
October 14, 2008
Assignee:
MDRNA, Inc.
Inventors:
Steven C. Quay, Henry R. Costantino, Mary S. Kleppe, Ching-Yuan Li